United States - English - NLM (National Library of Medicine)

professional complementary health formulas - belladonna 8x calcarea phosphorica 8x calcarea sulphurica 8x natrum sulphuricum 8x colchicum autumnale 12x formica rufa 12x naja tripudians 12x oleander 12x carbo animalis 15x amethyst 30x, 60x, 100x calcite 30x, 60x, 100x - temporarily relieves apathy, materialism, greed, boredom with life or difficulty finding meaning, constant worry, sadness, or general lack of purpose.* *claims based on traditional homeopathic practice, not accepted medical evidence. not fda evaluated.

Malaysia - English - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

amethyst pyrite services - nigella sativa -

United States - English - NLM (National Library of Medicine)

bryant ranch prepack - verapamil hydrochloride (unii: v3888oey5r) (verapamil - unii:cj0o37ku29) - verapamil hydrochloride 300 mg

Malaysia - English - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

dynapharm (m) sdn bhd - cloxacillin sodium -

Malaysia - English - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

dynapharm (m) sdn bhd - cloxacillin sodium -

Canada - English - Health Canada

taro pharmaceuticals inc - clindamycin (clindamycin phosphate) - solution - 1% - clindamycin (clindamycin phosphate) 1% - antibiotics

Canada - English - Health Canada

sun pharma canada inc - clindamycin (clindamycin hydrochloride) - capsule - 150mg - clindamycin (clindamycin hydrochloride) 150mg - lincomycins

Canada - English - Health Canada

sun pharma canada inc - clindamycin (clindamycin hydrochloride) - capsule - 300mg - clindamycin (clindamycin hydrochloride) 300mg - lincomycins

United States - English - NLM (National Library of Medicine)

ranbaxy laboratories inc. - omeprazole (unii: kg60484qx9) (omeprazole - unii:kg60484qx9) - omeprazole 40 mg - omeprazole delayed-release capsules is indicated for short-term treatment of active duodenal ulcer in adults. most patients heal within four weeks. some patients may require an additional four weeks of therapy.   omeprazole delayed-release capsules in combination with clarithromycin and amoxicillin, is indicated for treatment of patients with h. pylori infection and duodenal ulcer disease (active or up to 1-year history) to eradicate h. pylori in adults.   omeprazole delayed-release capsules in combination with clarithromycin is indicated for treatment of patients with h. pylori infection and duodenal ulcer disease to eradicate h. pylori in adults.   eradication of h. pylori has been shown to reduce the risk of duodenal ulcer recurrence [see clinical studies (14.1) and dosage and administration (2) ].   among patients who fail therapy, omeprazole delayed-release capsules with clarithromycin is more likely to be associated with the development of clarithromycin resistance as compared with triple therapy.

United States - English - NLM (National Library of Medicine)

astrazeneca pharmaceuticals lp - omeprazole magnesium (unii: 426qfe7xlk) (omeprazole - unii:kg60484qx9) - omeprazole 10 mg - prilosec is indicated for short-term treatment of active duodenal ulcer in adults. most patients heal within four weeks. some patients may require an additional four weeks of therapy. eradication of h. pylori has been shown to reduce the risk of duodenal ulcer recurrence. triple therapy prilosec in combination with clarithromycin and amoxicillin, is indicated for treatment of patients with h. pylori infection and duodenal ulcer disease (active or up to 1-year history) to eradicate h. pylori in adults. dual therapy prilosec in combination with clarithromycin is indicated for treatment of patients with h. pylori infection and duodenal ulcer disease to eradicate h. pylori in adults. among patients who fail therapy, prilosec with clarithromycin is more likely to be associated with the development of clarithromycin resistance as compared with triple therapy. in patients who fail therapy, susceptibility testing should be done. if resistance to clarithromycin is demonstrated or susceptibility testing is not pos